戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1 decrease in microglia activation in comparison with C57Bl/6 mice treated with AOM.
2 splasia, and CAC as well as in dysplastic tumors of C57BL/6 mice treated with azoxymethane-dextran sulfate sodium.
3 1r in NTS was evaluated by using Glp1r(-/-) mice or C57BL/6 mice treated with liraglutide.
4 survival/proliferation, and survival in brain tumor-bearing mice treated with PT2385 alone and in combination with standa
5 red blood cells and urine, and skin photosensitivity in CEP mice treated with deferiprone (1 or 3 mg/mL in drinking water
6                                          APOE*3-Leiden.CETP mice treated with anacetrapib had preserved levels of HDL-C a
7 omach and liver were collected from Mdr2KO and FVBN control mice treated with Ghr, des-octanoyl-ghrelin (DG) or vehicle.
8                                            Furthermore, DKO mice treated with S63845 displayed a significant decrease in
9                                                  We used DO mice treated with morphine to map quantitative trait loci for
10                                    However, C57BL/6J female mice treated with the benzimidazole inhibitor exhibited a sig
11 NA-sequencing was performed on liver samples collected from mice treated with a reference chemical (phenobarbital) or veh
12                               Isolated liver lysosomes from mice treated with either of two orally bioavailable class I P
13                                                 Tumors from mice treated with 5E1 had decreased blood vessel density and
14                                                Furthermore, mice treated with TGFbeta1-mim had lower levels of IgE, IgG1,
15 222 expression were shown in MLN-M isolated from 7 Gy GIARS mice treated with GL, and these macrophages did not display a
16 nslocation and subsequent sepsis were minimal in 7 Gy GIARS mice treated with GL.
17            However, no gallstones were formed in GPR30(-/-) mice treated with G-1.
18                                                          In mice treated with Leuko-Rapa, flow cytometry of disaggregated
19                                                          In mice treated with SS1P, proximal tubular cells are damaged an
20                                                          In mice treated with topical 5-fluorouracil, use of STAR particl
21 an facilitate rapid recovery of hematopoietic components in mice treated with the endoradiotherapeutic agent (153)Sm-EDTM
22 r erythroid 2-related factor 2 expression was also found in mice treated with MIA-690 and MR-409.
23 y weight, we found that the decrease in body weight gain in mice treated with metformin is not directly attributable to i
24 produced in mice lacking Bruton tyrosine kinase, but not in mice treated with 4 weeks of acalabrutinib, a more specific B
25        Strikingly, IL-6 blockade attenuates disease only in mice treated with IFN-I.
26 nflammation and tissue damage were significantly reduced in mice treated with metronidazole when combined with anti-E. hi
27                     Histological sections of lung tumors in mice treated with MSU-42011 exhibited reduced cell density an
28                                                   Ldlr(-/-) mice treated with 2-HOBA have reduced MDA-LDL and MDA-HDL lev
29                  Compared to hypercholesterolemic Ldlr(-/-) mice treated with vehicle or 4-HOBA, a nonreactive analogue,
30                                         Cdkl5 knockout male mice treated with isoform 1 via intrajugular injection at age
31 mpared to their controls and decrease in serum of Mdr2(-/-) mice treated with 5HTR2A/2B/2C antagonists compared to untrea
32 (G609G/G609G)Mmp13(-/-) mice or Lmna(G609G/G609G)Mmp13(+/+) mice treated with a MMP inhibitor show lower SMC loss in the
33 Npr1(-/-) ), 2-copy (Npr1(+/+) ), and 4-copy (Npr1(++/++) ) mice treated with GC inhibitor, A71915 and cGMP-dependent pro
34 activation on gene expression and phenotype of the liver of mice treated with valproic acid (VPA), or 2-propylpentanoic a
35        Finally, expression of Ahr in the enteric neurons of mice treated with antibiotics partially restores intestinal m
36 ally, vascular function was improved in diabetic vessels of mice treated with MCC950 (P < 0.05).
37                   We performed electrophysiology studies on mice treated with ibrutinib to assess inducibility of AF.
38  were observed at the protein level in the brain of APP/PS1 mice treated with miRCD33 vector.
39 length of survival from 15 to 65 days in the Scn8a-R1872W/+ mice treated with ASO.
40 levated in the placenta of pregnant ZIKV-infected Rag1(-/-) mice treated with an anti-IFNAR Ab, primarily at the end of p
41 s were markedly decreased in rmCIRP-injected mice or septic mice treated with LP17.
42 Cortical thickness was higher with co-treatment than in the mice treated with PTH alone.
43 to sort the glial and vascular cells from the brains of the mice treated with LPS at different time points, and RNA-seq w
44                                         In the liver of the mice treated with OCA, the levels of cytochrome P450 potentia
45                                 Moreover, 25% (3/12) of the mice treated with the combination approach showed complete tu
46 1alpha protein levels and bone regeneration, as compared to mice treated with vehicle control.
47                                      We also used wild-type mice treated with the SULT1E1 inhibitor triclosan to determin
48             However, reduction was incomplete compared with mice treated with human FVIII concentrate, and no difference
49                                             Furthermore, WT mice treated with P2X4 allosteric agonist ivermectin had exac
50  ivermectin had exacerbated renal IR injury whereas P2X4 WT mice treated with a selective P2X4 antagonist (5-BDBD) were p